JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 214 filers reported holding JUNO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $476,000 | +9.2% | 10,407 | +7.0% | 0.00% | – |
| Q3 2017 | $436,000 | +57.4% | 9,728 | +5.2% | 0.00% | – |
| Q2 2017 | $277,000 | -39.0% | 9,248 | -54.8% | 0.00% | – |
| Q1 2017 | $454,000 | +57.6% | 20,463 | +42.3% | 0.00% | – |
| Q4 2016 | $288,000 | -32.6% | 14,379 | +1.0% | 0.00% | – |
| Q3 2016 | $427,000 | +42600.0% | 14,238 | +37368.4% | 0.00% | – |
| Q2 2016 | $1,000 | -99.9% | 38 | -99.8% | 0.00% | – |
| Q1 2016 | $816,000 | +1940.0% | 21,400 | +2277.8% | 0.00% | – |
| Q4 2015 | $40,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|